Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018264HBVENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS30007874HIVENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS30082824HIVENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS30052178HIVENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS30052179HIVENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS20001238HPVENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS20055080HPVENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS44003313HTLV-1ENSG00000064012.24protein_codingCASP8NoYes841Q14790
TVIS44029149HTLV-1ENSG00000064012.24protein_codingCASP8NoYes841Q14790
TCGA Plot Options
Drug Information
GeneCASP8
DrugBank IDDB05103
Drug NameAN-9
Target IDBE0003460
UniProt IDQ14790
Regulation Typeregulator
PubMed IDs16373710
CitationsEntin-Meer M, Rephaeli A, Yang X, Nudelman A, VandenBerg SR, Haas-Kogan DA: Butyric acid prodrugs are histone deacetylase inhibitors that show antineoplastic activity and radiosensitizing capacity in the treatment of malignant gliomas. Mol Cancer Ther. 2005 Dec;4(12):1952-61. doi: 10.1158/1535-7163.MCT-05-0087.
GroupsInvestigational
Direct ClassificationFatty acid esters
SMILESCCCC(=O)OCOC(=O)C(C)(C)C
Pathways
PharmGKB
ChEMBLCHEMBL100014